Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Salivary biomarkers and periodontal disease progression

Official title: Evaluation of Salivary Biomarkers Associated With Bone Remodeling in the Transition From Periodontal Health to Disease

Run by Suleyman Demirel University · NCT07661784 · Data updated 2026-11-12

This study tests whether certain salivary biomarkers can reflect progression from healthy gums to gingivitis and periodontitis in adults.

More Periodontitis trials

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment240 (estimated)
SponsorSuleyman Demirel University
Academic / other
Locations1 site (Isparta)
StatusRecruiting
StartedJuly 10, 2025
Main results expectedJuly 10, 2026
Study endsAugust 30, 2026
Registry record updatedJune 22, 2026
Trial IDNCT07661784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–65 who are periodontally healthy, have gingivitis, or have periodontitis and can provide informed consent.

Probably not a fit

Patients with conditions or treatments known to affect saliva biomarkers or with recent periodontal therapy may not benefit from the biomarker findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study analyzes saliva samples from adults aged 18–65 with periodontal health, gingivitis, or periodontitis. Researchers measure biomarkers related to bone remodeling and inflammation (IL-17, IL-23, IL-6, TGF-β, RANKL, OPG) using ELISA and compare levels across disease stages. The goal is to see if these biomarkers correlate with disease severity and dental parameters, which could support earlier diagnosis and personalized approaches. Participants are classified by established periodontal staging and grading criteria and provide informed consent. The study is conducted at Suleyman Demirel University in Isparta, Turkey.

Why it matters

Potential benefit: If successful, the findings could improve understanding of disease activity and support development of biomarker-based tools for early diagnosis or personalized treatment planning.

How similar studies have gone: Prior research suggests salivary biomarkers can reflect inflammatory and bone remodeling processes in periodontal disease, supporting feasibility of this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Adults aged 18-65 years Systemically healthy individuals Individuals classified as periodontally healthy, gingivitis, or periodontitis according to clinical periodontal examination Ability and willingness to provide informed consent

Exclusion Criteria:

Presence of systemic diseases affecting periodontal status (e.g., diabetes mellitus, immunological disorders) Use of antibiotics or anti-inflammatory drugs within the last 3 months History of periodontal treatment within the last 6 months Pregnancy or lactation Smoking (optional ) Any condition that may affect salivary biomarker levels

Where it's running

  • Suleyman Demirel University
    Isparta, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.